Key result
Mechanical fragmentation with or without pharmacologic thrombolysis is highlighted as a therapeutic option for patients with massive pulmonary embolism or contraindications to anticoagulation.
Why the study?
Does mechanical fragmentation with or without pharmacologic thrombolysis improve outcomes in patients with massive pulmonary embolism?
Does mechanical fragmentation with or without pharmacologic thrombolysis improve outcomes in patients with massive pulmonary embolism?
Answers are grounded in this paper and cite their sources.
Mechanical fragmentation with or without pharmacologic thrombolysis is a viable therapeutic option for massive pulmonary embolism, particularly when anticoagulation is contraindicated or patients are in extremis.
Pulmonary embolism (PE) is a major cause of morbidity and mortality in the United States. Patients with massive PE have a high mortality rate, with two of every three deaths occurring in the first hour. The mainstay of treatment for PE is anticoagulation. However, when the patient is in extremis, intravenous lysis of the clot is indicated. Recently, mechanical fragmentation with or without pharmacologic thrombolysis has been shown to have a role in therapy for patients with massive PE, as well as in those patients who have a contraindication to anticoagulation. We discuss our experience with mechanical fragmentation in the treatment of PE and review the literature.
No takes yet. Share an insight, caveat, or question.
Rosenblum et al. (2008) conducted a review in Acute Pulmonary Embolism. Mechanical fragmentation with or without pharmacologic thrombolysis was evaluated. Mechanical fragmentation with or without pharmacologic thrombolysis is highlighted as a therapeutic option for patients with massive pulmonary embolism or contraindications to anticoagulation.
Synapse has enriched 10 related papers. Consider them for comparative context: